You are now leaving our website. Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.
AdministrationDOSAGE RECOMMENDATION In stroke and TBI Cerebrolysin should be administered as an adjunctive treatment to standard TBI care. The administration initiated optimally as soon as…
Terms of Use Last updated: 11.04.2018 1. Scope of Agreement 1.1. The use of the services on the non-public product sites on www.cerebrolysin.com ("Website") is offered to you by EVER Neuro…
Disclaimer EVER Pharma undertakes all appropriate effort to make correct and complete information available on this website, but assumes no responsibility, guarantees or liability whatsoever that…
Country specific informationRussiaWWW.CEREBROLYSIN.RUWWW.NEUROLOGIC.RUUkrainewww.cerebrolysin.com.uaKazakhstanwww.cerebrolysin.kzwww.insult.kzPolandwww.neuroaktywacja.plLatin…
Disease Traumatic brain injury (TBI) affects approx. 15 million1 individuals annually worldwide and is one of the leading causes of death. It is associated with high rates of hospitalization,…
Clinical efficacy and patient benefits To date, more than 3000 patients have been included in clinical trials evaluating the efficacy of Cerebrolysin in Alzheimer's disease and vascular dementia.…
